Strategies to decrease cardiovascular mortality in patients with end-stage renal disease

被引：11
|
作者：
Dikow, R
Adamczak, M
Henriquez, DE
Ritz, E
机构：
[1] Heidelberg Univ, Dept Internal Med, D-69115 Heidelberg, Germany
[2] Heidelberg Univ, Dept Internal Med, Heidelberg, Germany
[3] L Warynski Silesian Med Acad, Dept Nephrol Endocrinol & Metab Dis, Katowice, Poland
来源：
KIDNEY INTERNATIONAL | 2002年 / 61卷
关键词：
uremia; hypertension; anemia; sympathetic activity; dyslipidemia;
D O I：
10.1046/j.1523-1755.61.s80.3.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Today patients with chronic renal failure die no longer from the direct sequelae of uremia, except in underdeveloped countries. Nevertheless, the life expectancy of dialysed patients continues to be severely reduced, mainly as a consequence of fatal cardiovascular events (CV). The excess cardiovascular risk is demonstrable even in early stages of renal failure and remains elevated to some extent even after renal transplantation. Reversing the excessive cardiovascular risk is currently the greatest challenge to clinical nephrology.
引用
收藏
页码：S5 / S10
页数：6
相关论文
共 50 条
  • [1] Familiality of Cardiovascular Mortality in End-Stage Renal Disease Patients
    Naiman, Natalie
    Cheung, Alfred K.
    Goldfarb-Rumyantzev, Alexander S.
    AMERICAN JOURNAL OF NEPHROLOGY, 2009, 29 (03) : 237 - 243
  • [2] Cardiovascular mortality in end-stage renal disease
    Collins, AJ
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2003, 325 (04): : 163 - 167
  • [3] Cardiovascular disease in end-stage renal disease patients
    Collins, AJ
    Li, SL
    Ma, JZ
    Herzog, C
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) : S26 - S29
  • [4] Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease
    Buccianti, G
    Baragetti, I
    Bamonti, F
    Furiani, S
    Dorighet, V
    Patrosso, C
    JOURNAL OF NEPHROLOGY, 2004, 17 (03) : 405 - 410
  • [5] The cardiovascular burden of end-stage renal disease patients
    Cianciolo, G.
    Donati, G.
    La Manna, G.
    Ferri, A.
    Cuna, V.
    Ubaldi, G.
    Corsini, S.
    Lanci, N.
    Coli, L.
    Stefoni, S.
    MINERVA UROLOGICA E NEFROLOGICA, 2010, 62 (01) : 51 - 65
  • [6] Cardiovascular calcification in patients with end-stage renal disease
    Pecovnik-Balon, B
    THERAPEUTIC APHERESIS AND DIALYSIS, 2005, 9 (03) : 208 - 210
  • [7] Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease
    Shinohara, K
    Shoji, T
    Emoto, M
    Tahara, H
    Koyama, H
    Ishimura, E
    Miki, T
    Tabata, T
    Nishizawa, Y
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (07): : 1894 - 1900
  • [8] Bone mineral density in end-stage renal disease patients is a predictor of cardiovascular mortality
    Mazurenko, S. O.
    Enkin, A. A.
    Vasiliev, A. N.
    BONE, 2011, 48 : S200 - S200
  • [9] Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients
    Fung, F
    Sherrard, DJ
    Gillen, DL
    Wong, C
    Kestenbaum, B
    Seliger, S
    Ball, A
    Stehman-Breen, C
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (02) : 307 - 314
  • [10] Cardiovascular disease in end-stage renal disease
    Park, Jung Tak
    Oh, Hyung Jung
    Kang, Shin-Wook
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2013, 56 (07): : 576 - 582
12345